|
|
||||||||
Clinical Chemistry, Vol 22, 749-753, Copyright © 1976 by American Association for Clinical Chemistry
V Spiehler, L Sun, DS Miyada, SG Sarandis, ER Walwick, MW Klein, DB Jordan and B Jessen
Sera from epileptic patients were assayed for phenobarbital and diphenylhydantoin by four different analytical procedures. Quantitative results obtained by radioimmunoassay (I) and enzyme immunoassay (II) were compared to each other and to the results obtained on aliquots of the same sample by gas-liquid chromatography (III) and ultraviolet spectrophotometry (IV). For phenobarbital the correlation coefficients were I vs. II, 0.909; I vs. III, 0.947; II vs. III, 0.917; I vs. IV, 0.950; II vs. IV, 0.953. For diphenylhydantoin the correlation coefficients were I vs. II, 0.953; I vs. III, 0.951; II vs. III, 0.957; I vs. IV, 0.862; II vs. IV, 0.898. The immunoassays can be substituted for liquid chromatography or ultraviolet spectrophotometry without changing the resulting clinical interpretations.
The following articles in journals at HighWire Press have cited this article:
![]() |
W. R. Garnett, B. L. Carter, and J. M. Pellock Effect of Calcium and Antacids on Phenytoin Bioavailability Arch Neurol, July 1, 1980; 37(7): 467 - 467. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |